Co-Diagnostics Inc. Common Stock is a biotech company specializing in innovative molecular diagnostics for infectious diseases. With its proprietary CoPrimer technology, the company offers accurate and cost-effective diagnostic solutions, revolutionizing the field of medical testing. Utilizing cutting-edge science, Co-Diagnostics is poised for continued growth and success in the global healthcare industry.
